atai and Beckley Psytech plan to meet with the U.S. Food and Drug Administration (FDA) and other regulatory agencies to finalize the Phase 3 trial design.
Enhance strategies to drive sustainability, global Reach and digital transformation for a trillion-dollar future
Durvalumab in combination with carboplatin and paclitaxel is indicated for the first-line treatment of adults with primary advanced or recurrent endometrial cancer who are candidates for systemic therapy
The iStent platform uses tiny surgical implants to lower eye pressure by restoring the eye’s natural fluid drainage system in patients with glaucoma
Lyfius Pharma restarts operations at Penicillin-G manufacturing facility
The approval in China is supported by a robust local clinical development program confirming the drug’s safety, tolerability, and efficacy profile
Granules India receives 1 observation from USFDA for Chantilly facility
Acquisition to be followed by merger; strengthens Torrent’s IPM market presence
Prucalopride Tablets are bioequivalent to Motegrity Tablets, 1 mg and 2 mg, of Takeda Pharmaceuticals USA
Viatel bioresorbable polymers are increasingly used in dental and orthopedic implants
Subscribe To Our Newsletter & Stay Updated
